{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T03:44:12Z","timestamp":1786160652808,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019000","name":"Ministry of National Defense Medical Affairs Bureau","doi-asserted-by":"publisher","award":["MND-MAB-110-010"],"award-info":[{"award-number":["MND-MAB-110-010"]}],"id":[{"id":"10.13039\/501100019000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019000","name":"Ministry of National Defense Medical Affairs Bureau","doi-asserted-by":"publisher","award":["MND-MAB-C01\\u2013111002"],"award-info":[{"award-number":["MND-MAB-C01\\u2013111002"]}],"id":[{"id":"10.13039\/501100019000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 114-2314-B-016-049"],"award-info":[{"award-number":["NSTC 114-2314-B-016-049"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112\\u20132314-B-016-049"],"award-info":[{"award-number":["NSTC 112\\u20132314-B-016-049"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["MOST 109\\u20132314-B-016-044"],"award-info":[{"award-number":["MOST 109\\u20132314-B-016-044"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["MOST 110\\u20132314-B-016-041"],"award-info":[{"award-number":["MOST 110\\u20132314-B-016-041"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020950","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-E-110224"],"award-info":[{"award-number":["TSGH-E-110224"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-C03\\u2013112033"],"award-info":[{"award-number":["TSGH-C03\\u2013112033"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-PH_E_111010"],"award-info":[{"award-number":["TSGH-PH_E_111010"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-C01\\u2013113027"],"award-info":[{"award-number":["TSGH-C01\\u2013113027"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-E-110191"],"award-info":[{"award-number":["TSGH-E-110191"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-PH_E_112010"],"award-info":[{"award-number":["TSGH-PH_E_112010"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.intimp.2025.115189","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T19:32:40Z","timestamp":1752607960000},"page":"115189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Chalcone derivative 1m mitigates hepatic fibrosis and inflammation, enhances cholesterol efflux and reduces atherosclerosis"],"prefix":"10.1016","volume":"162","author":[{"given":"Chih-Feng","family":"Lien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Sheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Yuh","family":"Chern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rou-Ling","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sy-Jou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jhen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Yen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Sung","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Lueng","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7855","key":"10.1016\/j.intimp.2025.115189_bb0005","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.intimp.2025.115189_bb0010","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4065\/mcp.2009.0365","article-title":"Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma","volume":"85","author":"Calderon","year":"2010","journal-title":"Mayo Clin. Proc."},{"issue":"12","key":"10.1016\/j.intimp.2025.115189_bb0015","doi-asserted-by":"crossref","first-page":"7762","DOI":"10.1021\/acs.chemrev.7b00020","article-title":"Chalcone: a privileged structure in medicinal chemistry","volume":"117","author":"Zhuang","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.intimp.2025.115189_bb0020","article-title":"Pharmacological properties of chalcones: a review of preclinical including molecular mechanisms and clinical evidence","volume":"11","author":"Salehi","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115189_bb0025","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1080\/09168451.2019.1699396","article-title":"Low-dose phloretin alleviates diabetic atherosclerosis through endothelial KLF2 restoration","volume":"84","author":"Xia","year":"2020","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.intimp.2025.115189_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154117","article-title":"Isoliquiritigenin alleviates liver fibrosis through caveolin-1-mediated hepatic stellate cells ferroptosis in zebrafish and mice","volume":"101","author":"Huang","year":"2022","journal-title":"Phytomedicine"},{"issue":"7","key":"10.1016\/j.intimp.2025.115189_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23071620","article-title":"Chalcone derivatives enhance ATP-binding cassette transporters A1 in human THP-1 macrophages","volume":"23","author":"Teng","year":"2018","journal-title":"Molecules"},{"issue":"23","key":"10.1016\/j.intimp.2025.115189_bb0040","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1111\/bph.15175","article-title":"A chalcone derivative, 1m-6, exhibits atheroprotective effects by increasing cholesterol efflux and reducing inflammation-induced endothelial dysfunction","volume":"177","author":"Chen","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115189_bb0045","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","article-title":"Mechanisms and regulation of cholesterol homeostasis","volume":"21","author":"Luo","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.intimp.2025.115189_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2021.101109","article-title":"Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis","volume":"83","author":"Li","year":"2021","journal-title":"Prog. Lipid Res."},{"issue":"6","key":"10.1016\/j.intimp.2025.115189_bb0055","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"issue":"12","key":"10.1016\/j.intimp.2025.115189_bb0060","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/embo-reports\/kvf238","article-title":"Liver receptor homolog 1 controls the expression of the scavenger receptor class B type I","volume":"3","author":"Schoonjans","year":"2002","journal-title":"EMBO Rep."},{"issue":"1","key":"10.1016\/j.intimp.2025.115189_bb0065","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/hq0102.102588","article-title":"Transgenic expression of cholesterol-7-alpha-hydroxylase prevents atherosclerosis in C57BL\/6J mice","volume":"22","author":"Miyake","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.intimp.2025.115189_bb0070","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1194\/jlr.M400167-JLR200","article-title":"High-level expression of ABCG5 and ABCG8 attenuates diet-induced hypercholesterolemia and atherosclerosis in Ldlr\u2212\/\u2212 mice","volume":"45","author":"Wilund","year":"2004","journal-title":"J. Lipid Res."},{"issue":"4","key":"10.1016\/j.intimp.2025.115189_bb0075","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cmet.2014.07.023","article-title":"SUMOylation-dependent LRH-1\/PROX1 interaction promotes atherosclerosis by decreasing hepatic reverse cholesterol transport","volume":"20","author":"Stein","year":"2014","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.intimp.2025.115189_bb0080","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jhep.2018.07.019","article-title":"Statins: old drugs as new therapy for liver diseases?","volume":"70","author":"Pose","year":"2019","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115189_bb0085","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/liv.13308","article-title":"Hepatotoxicity of statins and other lipid-lowering agents","volume":"37","author":"Bjornsson","year":"2017","journal-title":"Liver Int."},{"key":"10.1016\/j.intimp.2025.115189_bb0090","article-title":"Severe liver injury associated with high-dose atorvastatin therapy","volume":"9","author":"Saha","year":"2021","journal-title":"J. Investig. Med. High Impact Case Rep."},{"issue":"2","key":"10.1016\/j.intimp.2025.115189_bb0095","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10557-020-07060-3","article-title":"Dietary cholesterol exacerbates statin-induced hepatic toxicity in Syrian Golden hamsters and in patients in an observational cohort study","volume":"35","author":"Yu","year":"2021","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"1","key":"10.1016\/j.intimp.2025.115189_bb0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41392-023-01690-3","article-title":"Targeting proprotein convertase subtilisin\/kexin type 9 (PCSK9): from bench to bedside","volume":"9","author":"Bao","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.intimp.2025.115189_bb0105","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.21579","article-title":"Quantifying anomalous intestinal sterol uptake, lymphatic transport, and biliary secretion in Abcg8(\u2212\/\u2212) mice","volume":"45","author":"Wang","year":"2007","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.intimp.2025.115189_bb0110","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cmet.2016.07.016","article-title":"Beneficial and adverse effects of an LXR agonist on human lipid and lipoprotein metabolism and circulating neutrophils","volume":"24","author":"Kirchgessner","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2025.115189_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.07.010","article-title":"The challenges and promise of targeting the liver X receptors for treatment of inflammatory disease","volume":"181","author":"Fessler","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.intimp.2025.115189_bb0120","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1161\/ATVBAHA.109.195693","article-title":"Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo","volume":"30","author":"Yasuda","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115189_bb0125","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/mol.116.105213","article-title":"Identification of a novel liver X receptor agonist that regulates the expression of key cholesterol homeostasis genes with distinct pharmacological characteristics","volume":"91","author":"Li","year":"2017","journal-title":"Mol. Pharmacol."},{"issue":"7","key":"10.1016\/j.intimp.2025.115189_bb0130","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1194\/jlr.C400002-JLR200","article-title":"The orphan nuclear receptor LRH-1 activates the ABCG5\/ABCG8 intergenic promoter","volume":"45","author":"Freeman","year":"2004","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.intimp.2025.115189_bb0135","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/01.ATV.20.3.721","article-title":"Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse","volume":"20","author":"Kozarsky","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"12","key":"10.1016\/j.intimp.2025.115189_bb0140","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.1073\/pnas.96.12.6660","article-title":"CPF: an orphan nuclear receptor that regulates liver-specific expression of the human cholesterol 7alpha-hydroxylase gene","volume":"96","author":"Nitta","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2025.115189_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155774","article-title":"Inhibition of PCSK9 prevents and alleviates cholesterol gallstones through PPARalpha-mediated CYP7A1 activation","volume":"152","author":"Chen","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.intimp.2025.115189_bb0150","series-title":"Mitigation of High-Fat Diet-Induced Hepatic Steatosis by Thyme (Thymus Quinquecostatus Celak) Polyphenol-Rich Extract (TPE): Insights into Gut Microbiota Modulation and Bile Acid Metabolism, Food Funct","author":"Sheng","year":"2024"},{"key":"10.1016\/j.intimp.2025.115189_bb0155","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.trsl.2016.06.003","article-title":"Genomics of human fatty liver disease reveal mechanistically linked lipid droplet-associated gene regulations in bland steatosis and nonalcoholic steatohepatitis","volume":"177","author":"Sahini","year":"2016","journal-title":"Transl. Res."},{"key":"10.1016\/j.intimp.2025.115189_bb0160","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.2147\/CMAR.S162887","article-title":"LRH-1 drives hepatocellular carcinoma partially through induction of c-myc and cyclin E1, and suppression of p21","volume":"10","author":"Xiao","year":"2018","journal-title":"Cancer Manag. Res."},{"issue":"14","key":"10.1016\/j.intimp.2025.115189_bb0165","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease","volume":"363","author":"Targher","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2025.115189_bb0170","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.phrs.2017.11.022","article-title":"Chalcones as putative hepatoprotective agents: preclinical evidence and molecular mechanisms","volume":"129","author":"Karimi-Sales","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.intimp.2025.115189_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/cells10051097","article-title":"Pathophysiology and treatment options for hepatic fibrosis: can it be completely cured?","volume":"10","author":"Khanam","year":"2021","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.intimp.2025.115189_bb0180","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1074\/jbc.RA118.005761","article-title":"Transforming growth factor beta (TGFbeta) cross-talk with the unfolded protein response is critical for hepatic stellate cell activation","volume":"294","author":"Liu","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"18","key":"10.1016\/j.intimp.2025.115189_bb0185","doi-asserted-by":"crossref","first-page":"6799","DOI":"10.1128\/MCB.00579-06","article-title":"Liver receptor homolog 1 is a negative regulator of the hepatic acute-phase response","volume":"26","author":"Venteclef","year":"2006","journal-title":"Mol. Cell. Biol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115189_bb0190","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/biolre\/ioad025","article-title":"TGF-beta1 induced activations of Smad2 and miRNAs inhibit SF-1- and LRH-1-dependent CYP19 expression in rat Leydig cellsdagger","volume":"108","author":"Ma","year":"2023","journal-title":"Biol. Reprod."},{"issue":"49","key":"10.1016\/j.intimp.2025.115189_bb0195","doi-asserted-by":"crossref","first-page":"32920","DOI":"10.1074\/jbc.273.49.32920","article-title":"Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice","volume":"273","author":"Wang","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"27","key":"10.1016\/j.intimp.2025.115189_bb0200","doi-asserted-by":"crossref","first-page":"20368","DOI":"10.1074\/jbc.M000730200","article-title":"Relationship between expression levels and atherogenesis in scavenger receptor class B, type I transgenics","volume":"275","author":"Ueda","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"26","key":"10.1016\/j.intimp.2025.115189_bb0205","doi-asserted-by":"crossref","first-page":"23699","DOI":"10.1074\/jbc.M211233200","article-title":"Differential effects of scavenger receptor BI deficiency on lipid metabolism in cells of the arterial wall and in the liver","volume":"278","author":"Van Eck","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.intimp.2025.115189_bb0210","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1161\/CIRCRESAHA.122.320263","article-title":"Animal models of atherosclerosis-supportive notes and tricks of the trade","volume":"130","author":"Gistera","year":"2022","journal-title":"Circ. Res."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925011798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925011798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T03:33:20Z","timestamp":1786160000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925011798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":42,"alternative-id":["S1567576925011798"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115189","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chalcone derivative 1m mitigates hepatic fibrosis and inflammation, enhances cholesterol efflux and reduces atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115189","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115189"}}